INS and type 2 diabetes mellitus: Given these limitations, the aim of the current study was to develop a new animal model that allows targeted and sustained induction of discrete stages of type 2 diabetes where animals remain obese, exhibit mild-moderate hyperglycemia and retain the ability to produce insulin, or those that exhibit frank type 2 diabetes.